FLATLINING from Fulcrum Strategies
Ep. 24 - No, HHS’ purchase of Nplates is not for COVID-19 vaccines
Ep. 24 - No, HHS’ purchase of Nplates is not for COVID-19 vaccines
Hybrid CoE Research Report 2: Effective state practices against  disinformation: Four country case studies - Hybrid CoE - The European  Centre of Excellence for Countering Hybrid Threats

This week on the FLATLINING Podcast, Ron and Matthew venture down the COVID-19 vaccine conspiracy theory rabbit hole. When Matthew reported about the Department of Health and Human Services’ purchase of an acute radiation sickness drug last week, some jumped to say that “really the Nplate drug is used to treat thrombotic thrombocytopenia syndrome caused by COVID-19 vaccines.” Ron and Matthew dive into what thrombotic thrombocytopenia syndrome is and why the claim is bogus.

Tech is having a greater and greater influence in the world and healthcare is no exception. Matthew and Ron discuss some of the latest tech trends in healthcare, including the vast expansion of telemedicine and online charts and how artificial intelligence could play a major role going forward.


Let us know what you think in the comments below, email us at flatlining@substack.com, or tweet Matthew or Ron.

Subscribe to the FLATLINING Podcast on Apple PodcastsSpotify, the iHeartRadio appAmazon MusicGoogle Podcasts, and Audible.

Follow Matthew (@radioHandley) and Ron (@RonHowrigon) on Twitter.

Articles mentioned in this program:

Thrombocytopenia in COVID‑19 and vaccine‑induced thrombotic thrombocytopenia - PubMed.gov

An Update on COVID-19 Vaccine Induced Thrombotic Thrombocytopenia Syndrome and Some Management Recommendations - PubMed.gov

HHS purchases drug for use in radiological and nuclear emergencies - HHS.gov

HHS purchases Nplate, an acute radiation syndrome drug - Matthew Handley at FLATLINING.net

The Opposition Virus - Ron Howrigon at FLATLINING.net

10 observations and emerging health IT trends - Becker’s Health IT

This next-generation video game requires a prescription - Vox

FDA Permits Marketing of First Game-Based Digital Therapeutic to Improve Attention Function in Children with ADHD - FDA.gov

FLATLINING from Fulcrum Strategies


The FLATLINING Podcast brings you great healthcare analysis and discussion each week from industry experts who know their way around politics, economics, and a doctors office. Subscribe for more great content and check out the articles at www.FLATLINING.net.